查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826778

2025年全球腸溶軟膠囊市場報告

Enteric Softgel Capsules Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，腸溶軟膠囊市場穩定成長，預計2024年將達23.4億美元，2025年將達24.4億美元，複合年成長率為4.1%。預測期內的成長歸因於藥品需求的成長、人們對健康和營養的興趣日益濃厚、研發活動的增加、對軟膠囊保健品的需求以及消費者對預防性醫療保健意識的不斷提升。

預計未來幾年腸溶軟膠囊市場將穩定成長，到2029年將達到29.2億美元，複合年成長率為4.6%。預測期內成長的主要促進因素包括：對臨床試驗的關注度不斷提高、對線上平台的依賴度不斷提高、對預防性醫療保健的重視程度不斷提高，以及營養障礙發病率和認知度不斷提高。預測期內的主要趨勢包括技術進步、對臨床試驗的關注度不斷提高、製造流程創新、夥伴關係關係的加強以及產品創新。

腸溶軟膠囊採用特殊設計的保護性塗層，防止內容物暴露於胃酸中。這使得膠囊能夠在小腸中溶解，確保靶向釋放和吸收。此技術廣泛應用於益生菌、魚油和藥品等產品中，以保護敏感成分並最大程度地減少對胃的刺激。

腸溶軟膠囊主要分為明膠膠囊和非明膠膠囊。明膠膠囊是由明膠製成的小型可溶性容器，用於盛裝口服的粉末或液體物質。這些膠囊透過各種管道銷售，包括超級市場、大賣場、藥局和線上平台。這些膠囊用途廣泛，包括制酸劑和腸道調節劑、抗發炎劑、抗生素和抗菌劑、止咳感冒藥、保健品、維生素、膳食補充劑和其他治療用途。這些產品供應給各種終端用戶，包括製藥公司、營養保健品公司、化妝品公司和食品業。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，其中許多產品的國內替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供腸溶軟膠囊市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的腸溶軟膠囊市場細分、市場趨勢和商機，以及您在腸溶軟膠囊行業取得成功所需的數據。本腸溶軟膠囊市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年4.6%的預測成長率，較我們先前對該市場的預測略有下降0.3%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將提高來自印度和中國的腸溶軟膠囊的成本，從而減緩關鍵藥物的吸收速度並提高藥品生產成本，對美國造成阻礙。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

營養失調盛行率的上升預計將推動腸溶軟膠囊市場的成長。營養失調是由營養攝取不均衡造成的，例如必需維生素、礦物質、蛋白質、脂肪和碳水化合物的缺乏或過量。不良的飲食習慣、久坐不動的生活方式、獲取營養食品的管道有限、加工食品消費增加以及社會經濟障礙等因素導致了這些疾病的發病率上升。腸溶軟膠囊透過提供一層塗層來保護必需營養素免受胃酸侵蝕，從而實現腸道最佳吸收，從而解決了這些問題。這提高了營養素的生物利用度，並支持消化器官系統健康和營養平衡。例如，聯合國糧食及農業組織2023年的報告強調，到2022年，嚴重的糧食不安全狀況將影響2.8%的出口中亞（ECA）人口，受影響人數約為2,620萬人，比前一年增加。因此，營養失調盛行率的上升正在推動市場成長。

腸溶軟膠囊市場的主要企業正在利用植物來源技術進行創新，以提升產品性能和吸引力。植物來源腸溶軟膠囊採用植物來源材料而非動物源明膠製成，並透過腸溶衣實現靶向腸道釋放。 2022年10月，Sirio Pharmaceuticals推出了EnteriClear，這是一種植物來源解決方案，旨在保護酸敏感成分免於胃分解，而無需使用傳統包衣。此技術可確保提高生物有效性、促進腸道釋放並減少不適感，並具有非基因改造、無麩質和無糖等獨特優勢。 EnteriClear擁有穩定透明的外殼，無需低溫運輸儲存，是營養補充品品牌的理想選擇。

2024年8月，總部位於瑞士的運輸和物流公司Kuhne Holding AG從BC Partners收購了Aenova Group GmbH，收購金額未揭露。此次策略性收購旨在透過整合醫療保健和製藥資產來擴大Kuhne Holding AG的投資組合，並有望帶來強勁的財務回報和長期成長。 Aenova Group GmbH總部位於德國，專門生產各種劑型，包括片劑、膠囊和無菌液體。

腸溶軟膠囊市場涵蓋益生菌、止痛藥、消化酵素和維生素等產品的銷售。此市場的價值是指“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腸溶軟膠囊：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球腸溶軟膠囊市場：成長率分析
  • 全球腸溶軟膠囊市場表現：規模與成長，2019-2024
  • 全球腸溶軟膠囊市場預測：2024-2029年及2034年規模及成長
  • 全球腸溶軟膠囊：總目標市場（TAM）

第6章 市場細分

  • 全球腸溶軟膠囊市場：依類型、績效及預測，2019-2024年、2024-2029年、2034年
  • 明膠膠囊
  • 無明膠軟膠囊
  • 全球腸溶軟膠囊市場：依通路、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 超級市場和大賣場
  • 藥局和藥局
  • 網路商店
  • 全球腸溶軟膠囊市場：依應用、績效及預測，2019-2024年、2024-2029年、2034年
  • 制酸劑和腸道調節劑
  • 抗發炎藥物
  • 抗生素和抗菌藥物
  • 咳嗽和感冒藥
  • 保健品
  • 維生素和營養補充劑
  • 其他治療用途
  • 全球腸溶軟膠囊市場：依最終用戶、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥公司
  • 營養補充品公司
  • 化妝品公司
  • 食品工業
  • 全球腸溶軟膠囊市場：明膠膠囊細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 牛明膠軟膠囊
  • 豬肉明膠軟膠囊
  • 魚明膠軟膠囊
  • 全球腸溶軟膠囊市場：非明膠軟膠囊細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 植物來源的軟膠囊
  • 純素軟膠囊
  • 聚合物基軟膠囊

第7章 區域和國家分析

  • 全球腸溶軟膠囊市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球腸溶軟膠囊市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 腸溶軟膠囊市場：競爭格局
  • 腸溶軟膠囊市場：公司簡介
    • BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • United Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Herbalife Nutrition Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Catalent Pharma Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Sirio Pharma Co. Ltd.
  • NOW Health Group Inc.
  • Patheon
  • GELITA AG
  • Colorcon Inc.
  • Aenova Group GmbH
  • ProCaps Laboratories Inc.
  • CAPTEK Softgel International Inc.
  • Renown Pharmaceuticals Private Limited
  • Viva Pharmaceutical Inc.
  • Biofield Pharma Private Limited
  • CapsCanada Corporation
  • Natural Capsules Limited
  • Fuji Capsules Co. Ltd.
  • Conch Lifescience Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年腸溶軟膠囊市場：提供新機會的國家
  • 2029年腸溶軟膠囊市場：細分市場帶來新機會
  • 腸溶軟膠囊市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33705u

Enteric softgel capsules are specially designed with a protective coating that prevents their contents from being exposed to stomach acid. This allows the capsules to dissolve in the small intestine, ensuring targeted release and absorption. This technology is widely used for products such as probiotics, fish oil, and medications, protecting sensitive ingredients and minimizing stomach irritation.

The primary types of enteric softgel capsules are gelatin and non-gelatin capsules. Gelatin capsules are small, soluble containers made from gelatin, designed to hold powdered or liquid substances for oral consumption. These capsules are distributed through various channels, including supermarkets and hypermarkets, pharmacies and drug stores, and online platforms. They are used in multiple applications, such as antacid and antiflatulent preparations, anti-inflammatory drugs, antibiotic and antibacterial drugs, cough and cold remedies, health supplements, vitamins, dietary supplements, and other therapeutic purposes. These products serve diverse end users, including pharmaceutical, nutraceutical, and cosmeceutical companies, as well as the food industry.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The enteric softgel capsules market research report is one of a series of new reports from The Business Research Company that provides enteric softgel capsules market statistics, including enteric softgel capsules industry global market size, regional shares, competitors with an enteric softgel capsules market share, detailed enteric softgel capsules market segments, market trends and opportunities, and any further data you may need to thrive in the enteric softgel capsules industry. This enteric softgel capsules market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enteric softgel capsules market size has grown steadily in recent years. It will grow from $2.34 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increased demand for pharmaceuticals, increased focus on health and nutrition, an increase in R&D activities, demand for soft gel health supplements, and a rise in consumer knowledge of preventative healthcare.

The enteric softgel capsules market size is expected to see steady growth in the next few years. It will grow to $2.92 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing focus on clinical trials, increasing reliance on online platforms, increasing emphasis on preventive healthcare, increasing incidence of nutrition disorders, and increasing awareness. Major trends in the forecast period include technological advancements, focus on clinical trials, innovation in the manufacturing process, increasing partnerships, and product innovation.

The forecast of 4.6% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of enteric-coated softgel capsules sourced from India and China, thereby delaying critical medication absorption and elevating pharmaceutical manufacturing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of nutrition disorders is expected to drive the growth of the enteric softgel capsules market. Nutritional disorders arise from imbalances in nutrient intake, such as deficiencies or excesses of essential vitamins, minerals, proteins, fats, and carbohydrates. Factors such as poor dietary habits, sedentary lifestyles, limited access to nutritious food, increasing consumption of processed foods, and socio-economic barriers contribute to the growing incidence of these disorders. Enteric softgel capsules address these issues by delivering essential nutrients with a protective coating that shields them from stomach acid, enabling targeted release in the intestines for optimal absorption. This improves nutrient bioavailability and supports digestive health and nutritional balance. For example, a 2023 report by the Food and Agriculture Organization highlighted that severe food insecurity impacted 2.8% of the ECA population in 2022, affecting approximately 26.2 million people, an increase from the previous year. As a result, the increasing prevalence of nutrition disorders is driving market growth.

Leading companies in the enteric softgel capsule market are innovating with plant-based technologies to enhance product performance and appeal. Plant-based enteric softgels, made from plant-derived materials instead of animal-based gelatin, feature enteric coatings for targeted intestinal release. In October 2022, Sirio Pharma Co. introduced EnteriClear, a plant-based solution designed to protect acid-sensitive ingredients from stomach degradation without traditional coatings. This technology ensures improved bioavailability, intestinal release, reduced discomfort, and offers unique benefits such as being non-GMO, gluten-free, and sugar-free. With a stable, clear shell that does not require cold chain storage, EnteriClear is ideal for nutraceutical brands.

In August 2024, Kuhne Holding AG, a Switzerland-based transportation and logistics company, acquired Aenova Group GmbH from BC Partners for an undisclosed amount. This strategic acquisition aims to expand Kuhne Holding AG's investment portfolio by incorporating healthcare and pharmaceutical assets, expected to deliver strong financial returns and long-term growth. Aenova Group GmbH, based in Germany, specializes in the production of various dosage forms, including tablets, capsules, and sterile liquids.

Major players in the enteric softgel capsules market are BASF SE, Thermo Fisher Scientific Inc., United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd.

North America was the largest region in the enteric softgel capsules market in 2024. The regions covered in enteric softgel capsules report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the enteric softgel capsules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enteric softgel capsules market consists of sales of products including probiotics, pain relievers, digestive enzymes, and vitamins. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enteric Softgel Capsules Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enteric softgel capsules market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enteric softgel capsules ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enteric softgel capsules market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Gelatin Capsules; Non-Gelatin Softgel Capsules
  • 2) By Distribution Channel: Supermarkets And Hypermarkets; Pharmacy And Drug Stores; Online Stores
  • 3) By Application: Antacid And Antiflatulent Preparations; Anti-Inflammatory Drugs; Antibiotic And Antibacterial Drugs; Cough And Cold Preparations; Health Supplements; Vitamin And Dietary Supplements; Other Therapeutic Applications
  • 4) By End User: Pharmaceutical Companies; Nutraceutical Companies; Cosmeceutical Companies; Food Industry
  • Subsegments:
  • 1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules; Porcine Gelatin Softgel Capsules; Fish Gelatin Softgel Capsules
  • 2) By Non-Gelatin Softgel Capsules: Plant-based Softgel Capsules; Vegan Softgel Capsules; Polymer-Based Softgel Capsules
  • Companies Mentioned: BASF SE; Thermo Fisher Scientific Inc.; United Laboratories International Inc.; Herbalife Nutrition Ltd.; Catalent Pharma Solutions Inc.; Sirio Pharma Co. Ltd.; NOW Health Group Inc.; Patheon; GELITA AG; Colorcon Inc.; Aenova Group GmbH; ProCaps Laboratories Inc.; CAPTEK Softgel International Inc.; Renown Pharmaceuticals Private Limited; Viva Pharmaceutical Inc.; Biofield Pharma Private Limited; CapsCanada Corporation; Natural Capsules Limited; Fuji Capsules Co. Ltd.; Conch Lifescience Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enteric Softgel Capsules Market Characteristics

3. Enteric Softgel Capsules Market Trends And Strategies

4. Enteric Softgel Capsules Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Enteric Softgel Capsules Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Enteric Softgel Capsules PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Enteric Softgel Capsules Market Growth Rate Analysis
  • 5.4. Global Enteric Softgel Capsules Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Enteric Softgel Capsules Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Enteric Softgel Capsules Total Addressable Market (TAM)

6. Enteric Softgel Capsules Market Segmentation

  • 6.1. Global Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gelatin Capsules
  • Non-Gelatin Softgel Capsules
  • 6.2. Global Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Supermarkets And Hypermarkets
  • Pharmacy And Drug Stores
  • Online Stores
  • 6.3. Global Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antacid And Antiflatulent Preparations
  • Anti-Inflammatory Drugs
  • Antibiotic And Antibacterial Drugs
  • Cough And Cold Preparations
  • Health Supplements
  • Vitamin And Dietary Supplements
  • Other Therapeutic Applications
  • 6.4. Global Enteric Softgel Capsules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Cosmeceutical Companies
  • Food Industry
  • 6.5. Global Enteric Softgel Capsules Market, Sub-Segmentation Of Gelatin Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Gelatin Softgel Capsules
  • Porcine Gelatin Softgel Capsules
  • Fish Gelatin Softgel Capsules
  • 6.6. Global Enteric Softgel Capsules Market, Sub-Segmentation Of Non-Gelatin Softgel Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plant-based Softgel Capsules
  • Vegan Softgel Capsules
  • Polymer-Based Softgel Capsules

7. Enteric Softgel Capsules Market Regional And Country Analysis

  • 7.1. Global Enteric Softgel Capsules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Enteric Softgel Capsules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Enteric Softgel Capsules Market

  • 8.1. Asia-Pacific Enteric Softgel Capsules Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Enteric Softgel Capsules Market

  • 9.1. China Enteric Softgel Capsules Market Overview
  • 9.2. China Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Enteric Softgel Capsules Market

  • 10.1. India Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Enteric Softgel Capsules Market

  • 11.1. Japan Enteric Softgel Capsules Market Overview
  • 11.2. Japan Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Enteric Softgel Capsules Market

  • 12.1. Australia Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Enteric Softgel Capsules Market

  • 13.1. Indonesia Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Enteric Softgel Capsules Market

  • 14.1. South Korea Enteric Softgel Capsules Market Overview
  • 14.2. South Korea Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Enteric Softgel Capsules Market

  • 15.1. Western Europe Enteric Softgel Capsules Market Overview
  • 15.2. Western Europe Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Enteric Softgel Capsules Market

  • 16.1. UK Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Enteric Softgel Capsules Market

  • 17.1. Germany Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Enteric Softgel Capsules Market

  • 18.1. France Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Enteric Softgel Capsules Market

  • 19.1. Italy Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Enteric Softgel Capsules Market

  • 20.1. Spain Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Enteric Softgel Capsules Market

  • 21.1. Eastern Europe Enteric Softgel Capsules Market Overview
  • 21.2. Eastern Europe Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Enteric Softgel Capsules Market

  • 22.1. Russia Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Enteric Softgel Capsules Market

  • 23.1. North America Enteric Softgel Capsules Market Overview
  • 23.2. North America Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Enteric Softgel Capsules Market

  • 24.1. USA Enteric Softgel Capsules Market Overview
  • 24.2. USA Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Enteric Softgel Capsules Market

  • 25.1. Canada Enteric Softgel Capsules Market Overview
  • 25.2. Canada Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Enteric Softgel Capsules Market

  • 26.1. South America Enteric Softgel Capsules Market Overview
  • 26.2. South America Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Enteric Softgel Capsules Market

  • 27.1. Brazil Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Enteric Softgel Capsules Market

  • 28.1. Middle East Enteric Softgel Capsules Market Overview
  • 28.2. Middle East Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Enteric Softgel Capsules Market

  • 29.1. Africa Enteric Softgel Capsules Market Overview
  • 29.2. Africa Enteric Softgel Capsules Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Enteric Softgel Capsules Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Enteric Softgel Capsules Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Enteric Softgel Capsules Market Competitive Landscape And Company Profiles

  • 30.1. Enteric Softgel Capsules Market Competitive Landscape
  • 30.2. Enteric Softgel Capsules Market Company Profiles
    • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. United Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Herbalife Nutrition Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Catalent Pharma Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Enteric Softgel Capsules Market Other Major And Innovative Companies

  • 31.1. Sirio Pharma Co. Ltd.
  • 31.2. NOW Health Group Inc.
  • 31.3. Patheon
  • 31.4. GELITA AG
  • 31.5. Colorcon Inc.
  • 31.6. Aenova Group GmbH
  • 31.7. ProCaps Laboratories Inc.
  • 31.8. CAPTEK Softgel International Inc.
  • 31.9. Renown Pharmaceuticals Private Limited
  • 31.10. Viva Pharmaceutical Inc.
  • 31.11. Biofield Pharma Private Limited
  • 31.12. CapsCanada Corporation
  • 31.13. Natural Capsules Limited
  • 31.14. Fuji Capsules Co. Ltd.
  • 31.15. Conch Lifescience Co. Ltd.

32. Global Enteric Softgel Capsules Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Enteric Softgel Capsules Market

34. Recent Developments In The Enteric Softgel Capsules Market

35. Enteric Softgel Capsules Market High Potential Countries, Segments and Strategies

  • 35.1 Enteric Softgel Capsules Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Enteric Softgel Capsules Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Enteric Softgel Capsules Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer